These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 16476412)

  • 21. Catechol-O-methyltransferase Val158Met genotype variation is associated with prefrontal-dependent task performance in schizotypal personality disorder patients and comparison groups.
    Minzenberg MJ; Xu K; Mitropoulou V; Harvey PD; Finch T; Flory JD; New AS; Goldman D; Siever LJ
    Psychiatr Genet; 2006 Jun; 16(3):117-24. PubMed ID: 16691129
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tolcapone improves cognition and cortical information processing in normal human subjects.
    Apud JA; Mattay V; Chen J; Kolachana BS; Callicott JH; Rasetti R; Alce G; Iudicello JE; Akbar N; Egan MF; Goldberg TE; Weinberger DR
    Neuropsychopharmacology; 2007 May; 32(5):1011-20. PubMed ID: 17063156
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel protein isoform of catechol O-methyltransferase (COMT): brain expression analysis in schizophrenia and bipolar disorder and effect of Val158Met genotype.
    Tunbridge EM; Weinberger DR; Harrison PJ
    Mol Psychiatry; 2006 Feb; 11(2):116-7. PubMed ID: 16247488
    [No Abstract]   [Full Text] [Related]  

  • 24. Catechol-O-methyl transferase Val158Met gene polymorphism in schizophrenia: working memory, frontal lobe MRI morphology and frontal cerebral blood flow.
    Ho BC; Wassink TH; O'Leary DS; Sheffield VC; Andreasen NC
    Mol Psychiatry; 2005 Mar; 10(3):229, 287-98. PubMed ID: 15668720
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The high-activity Val allele of the catechol-O-methyltransferase gene predicts greater cognitive deterioration in patients with psychosis.
    Mata I; Arranz MJ; Staddon S; Lopez-Ilundain JM; Tabares-Seisdedos R; Murray RM
    Psychiatr Genet; 2006 Oct; 16(5):213-6. PubMed ID: 16969277
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prefrontal abnormalities, executive dysfunction and symptoms severity are modulated by COMT Val
    Rodríguez-Toscano E; Martínez K; Fraguas D; Janssen J; Pina-Camacho L; Arias B; Vieta E; Mezquida G; Amoretti S; Bernardo M; Castro-Fornieles J; Cuesta-Zorita MJ; Lobo A; González-Pinto A; Collado IC; Mané A; Arango C; Parellada M;
    Rev Psiquiatr Salud Ment (Engl Ed); 2022; 15(2):74-87. PubMed ID: 35840287
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Catechol-O-methyltransferase Val(158)Met association with parahippocampal physiology during memory encoding in schizophrenia.
    Di Giorgio A; Caforio G; Blasi G; Taurisano P; Fazio L; Romano R; Ursini G; Gelao B; Bianco LL; Papazacharias A; Sinibaldi L; Popolizio T; Bellomo A; Bertolino A
    Psychol Med; 2011 Aug; 41(8):1721-31. PubMed ID: 21144115
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DRD3, but not COMT or DRD2, genotype affects executive functions in healthy and first-episode psychosis adolescents.
    Bombin I; Arango C; Mayoral M; Castro-Fornieles J; Gonzalez-Pinto A; Gonzalez-Gomez C; Moreno D; Parellada M; Baeza I; Graell M; Otero S; Saiz PA; Patiño-Garcia A
    Am J Med Genet B Neuropsychiatr Genet; 2008 Sep; 147B(6):873-9. PubMed ID: 18351593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Catechol-O-methyltransferase genotype differentially contributes to the flexibility and stability of cognitive sets in patients with psychotic disorders and their first-degree relatives.
    Hochberger WC; Eskridge CLM; Bishop JR; Reilly JL; Rubin LH; Keedy S; Gershon ES; Tamminga CA; Pearlson GD; Ragozzino M; Keshavan MS; Sweeney JA; Hill SK
    Schizophr Res; 2020 Sep; 223():236-241. PubMed ID: 32829984
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Catechol O-methyltransferase Val158Met polymorphism is associated with cognitive performance in nondemented adults.
    de Frias CM; Annerbrink K; Westberg L; Eriksson E; Adolfsson R; Nilsson LG
    J Cogn Neurosci; 2005 Jul; 17(7):1018-25. PubMed ID: 16102234
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic variation in COMT and PRODH is associated with brain anatomy in patients with schizophrenia.
    Zinkstok J; Schmitz N; van Amelsvoort T; Moeton M; Baas F; Linszen D
    Genes Brain Behav; 2008 Feb; 7(1):61-9. PubMed ID: 17504246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Erythrocyte catechol-O-methyltransferase activity in psychotic twins.
    Floderus Y; Eberhard G; Witterberg L
    Clin Genet; 1981 May; 19(5):386-9. PubMed ID: 7296927
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current understanding of the interplay between catechol-O-methyltransferase genetic variants, sleep, brain development and cognitive performance in schizophrenia.
    Tucci V; Lassi G; Kas MJ
    CNS Neurol Disord Drug Targets; 2012 May; 11(3):292-8. PubMed ID: 22483299
    [TBL] [Abstract][Full Text] [Related]  

  • 34. No association between the Catechol-O-Methyltransferase (COMT) val158met polymorphism and cognitive improvement following cognitive remediation therapy (CRT) in schizophrenia.
    Greenwood K; Hung CF; Tropeano M; McGuffin P; Wykes T
    Neurosci Lett; 2011 Jun; 496(2):65-9. PubMed ID: 21458532
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diverse facets of COMT: from a plausible predictive marker to a potential drug target for schizophrenia.
    Gupta M; Kaur H; Jajodia A; Jain S; Satyamoorthy K; Mukerji M; Thirthalli J; ; Kukreti R
    Curr Mol Med; 2011 Dec; 11(9):732-43. PubMed ID: 21999147
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of COMT genotype on cognition in schizophrenia spectrum patients and their relatives.
    Lopez-Garcia P; Young Espinoza L; Molero Santos P; Marin J; Ortuño Sanchez-Pedreño F
    Psychiatry Res; 2013 Jul; 208(2):118-24. PubMed ID: 23102922
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cannabis use and age at onset of psychosis: further evidence of interaction with COMT Val158Met polymorphism.
    Estrada G; Fatjó-Vilas M; Muñoz MJ; Pulido G; Miñano MJ; Toledo E; Illa JM; Martín M; Miralles ML; Miret S; Campanera S; Bernabeu C; Navarro ME; Fañanás L
    Acta Psychiatr Scand; 2011 Jun; 123(6):485-92. PubMed ID: 21231925
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence that interactive effects of COMT and MTHFR moderate psychotic response to environmental stress.
    Peerbooms O; Rutten BP; Collip D; Lardinois M; Lataster T; Thewissen V; Rad SM; Drukker M; Kenis G; van Os J; Myin-Germeys I; van Winkel R
    Acta Psychiatr Scand; 2012 Mar; 125(3):247-56. PubMed ID: 22128864
    [TBL] [Abstract][Full Text] [Related]  

  • 39. COMT Val158Met genotype selectively alters prefrontal [18F]fallypride displacement and subjective feelings of stress in response to a psychosocial stress challenge.
    Hernaus D; Collip D; Lataster J; Ceccarini J; Kenis G; Booij L; Pruessner J; Van Laere K; van Winkel R; van Os J; Myin-Germeys I
    PLoS One; 2013; 8(6):e65662. PubMed ID: 23799032
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association study of a functional catechol-O-methyltransferase genetic polymorphism with age of onset, cognitive function, symptomatology and prognosis in chronic schizophrenia.
    Tsai SJ; Hong CJ; Liao DL; Lai IC; Liou YJ
    Neuropsychobiology; 2004; 49(4):196-200. PubMed ID: 15118357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.